AU746007B2 - Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones - Google Patents
Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones Download PDFInfo
- Publication number
- AU746007B2 AU746007B2 AU60562/98A AU6056298A AU746007B2 AU 746007 B2 AU746007 B2 AU 746007B2 AU 60562/98 A AU60562/98 A AU 60562/98A AU 6056298 A AU6056298 A AU 6056298A AU 746007 B2 AU746007 B2 AU 746007B2
- Authority
- AU
- Australia
- Prior art keywords
- group
- carbon atoms
- alkyl
- radical selected
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12018497A IL120184A (en) | 1997-02-09 | 1997-02-09 | Pharmaceutical compositions comprising permanently charged derivatives of steroid agonists or antagonists for preventing angiogenesis |
IL120184 | 1997-02-09 | ||
US08/833074 | 1997-04-02 | ||
US08/833,074 US6083990A (en) | 1997-04-02 | 1997-04-02 | Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones |
PCT/US1998/002176 WO1998034583A2 (en) | 1997-02-09 | 1998-02-04 | Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones |
Publications (2)
Publication Number | Publication Date |
---|---|
AU6056298A AU6056298A (en) | 1998-08-26 |
AU746007B2 true AU746007B2 (en) | 2002-04-11 |
Family
ID=26323367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU60562/98A Ceased AU746007B2 (en) | 1997-02-09 | 1998-02-04 | Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0981337A4 (de) |
JP (1) | JP2001511182A (de) |
AU (1) | AU746007B2 (de) |
CA (1) | CA2280181A1 (de) |
WO (1) | WO1998034583A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3046792B1 (fr) * | 2016-01-19 | 2018-02-02 | Les Laboratoires Servier | Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
JP7100019B2 (ja) * | 2016-08-19 | 2022-07-12 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 選択的エストロゲン受容体モジュレーター(serm)は、光受容体の変性に対する保護を付与する |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995026720A1 (en) * | 1994-04-04 | 1995-10-12 | Pharmos Corporation | Permanently ionic derivatives of steroid hormones and their antagonists |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2914561A (en) * | 1957-08-06 | 1959-11-24 | Wm S Merrell Co | Amine derivatives of triphenylethylene |
US2971001A (en) * | 1959-10-21 | 1961-02-07 | Wm S Merrell Co | Quaternary salts of triphenylethanols, -ethylenes, and -ethanes |
BE637389A (de) * | 1962-09-13 | |||
WO1994009764A1 (en) * | 1992-10-27 | 1994-05-11 | Nippon Kayaku Kabushiki Kaisha | Use of non steroidal anti estrogens for autoimmune diseases |
-
1998
- 1998-02-04 EP EP98903921A patent/EP0981337A4/de not_active Withdrawn
- 1998-02-04 CA CA002280181A patent/CA2280181A1/en not_active Abandoned
- 1998-02-04 WO PCT/US1998/002176 patent/WO1998034583A2/en not_active Application Discontinuation
- 1998-02-04 JP JP53487698A patent/JP2001511182A/ja not_active Abandoned
- 1998-02-04 AU AU60562/98A patent/AU746007B2/en not_active Ceased
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995026720A1 (en) * | 1994-04-04 | 1995-10-12 | Pharmos Corporation | Permanently ionic derivatives of steroid hormones and their antagonists |
Also Published As
Publication number | Publication date |
---|---|
EP0981337A4 (de) | 2003-03-12 |
JP2001511182A (ja) | 2001-08-07 |
WO1998034583A2 (en) | 1998-08-13 |
WO1998034583A3 (en) | 1998-11-05 |
CA2280181A1 (en) | 1998-08-13 |
AU6056298A (en) | 1998-08-26 |
EP0981337A2 (de) | 2000-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5650425A (en) | Permanently ionic derivatives of steroid hormones and their antagonists | |
US8367644B2 (en) | Methods and compounds useful to induce apoptosis in cancer cells | |
EP3638233B1 (de) | Tinostamustin zur verwendung bei der behandlung von eierstockkrebs | |
US6433012B1 (en) | Method for inhibiting inflammatory disease | |
JPH08502488A (ja) | 前立腺癌および初期神経悪性疾患に対するベンゾキノイドアンサマイシンの殺腫瘍活性 | |
JP2021505571A (ja) | 末梢t細胞リンパ腫および皮膚t細胞リンパ腫を治療するための組成物および方法 | |
JP6992952B2 (ja) | 血管石灰化の治療 | |
US7749962B2 (en) | Alpha 5 beta 1 and its ability to regulate the cell survival pathway | |
US6083990A (en) | Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones | |
AU746007B2 (en) | Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones | |
US20120252773A1 (en) | Method and composition for inhibiting cell proliferation and angiogenesis | |
KR100459484B1 (ko) | 엔-아세틸 파이토스핑고신과 다이메틸 파이토스핑고신을유효 성분으로 포함하는 방사선 치료 민감제 조성물 | |
JPS59500717A (ja) | 静細胞作用を有する医薬製剤 | |
KR20220043047A (ko) | 스핑고신-1-인산 수용체 효능제의 용도 | |
CN102006866A (zh) | 激酶蛋白结合抑制剂 | |
JP2024520111A (ja) | 不眠症を治療するための組成物及びその使用 | |
EP0897720A1 (de) | Verwendung von droloxifen zur vorbeugung von mammakarzinom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NB | Applications allowed - extensions of time section 223(2) |
Free format text: THE TIME IN WHICH TO OBTAIN ACCEPTANCE HAS BEEN EXTENDED TO 20020218 |
|
FGA | Letters patent sealed or granted (standard patent) |